Regions Financial Corp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Buy |
+10,014
| New | +$1.88M | 0.01% | 382 |
|
|
2026
Q1 | – | Sell |
-9,491
| Closed | -$1.74M | – | 863 |
|
|
2025
Q4 | $1.74M | Buy |
9,491
+146
| +2% | +$25.6K | 0.01% | 400 |
|
|
2025
Q3 | $1.43M | Sell |
9,345
-5,330
| -36% | -$807K | 0.01% | 433 |
|
|
2025
Q2 | $2.05M | Sell |
14,675
-1,086
| -7% | -$152K | 0.01% | 377 |
|
|
2025
Q1 | $2.32M | Sell |
15,761
-882
| -5% | -$128K | 0.02% | 342 |
|
|
2024
Q4 | $2.18M | Sell |
16,643
-1,291
| -7% | -$181K | 0.02% | 354 |
|
|
2024
Q3 | $2.79M | Buy |
17,934
+859
| +5% | +$139K | 0.02% | 315 |
|
|
2024
Q2 | $2.66M | Buy |
17,075
+11,345
| +198% | +$1.71M | 0.02% | 312 |
|
|
2024
Q1 | $776K | Sell |
5,730
-211
| -4% | -$27.9K | 0.01% | 533 |
|
|
2023
Q4 | $800K | Buy |
5,941
+378
| +7% | +$49.1K | 0.01% | 513 |
|
|
2023
Q3 | $753K | Buy |
5,563
+19
| +0.3% | +$2.6K | 0.01% | 504 |
|
|
2023
Q2 | $794K | Sell |
5,544
-6,459
| -54% | -$950K | 0.01% | 510 |
|
|
2023
Q1 | $1.67M | Buy |
12,003
+390
| +3% | +$52.5K | 0.02% | 387 |
|
|
2022
Q4 | $1.57M | Sell |
11,613
-469
| -4% | -$58.8K | 0.01% | 392 |
|
|
2022
Q3 | $1.32M | Buy |
12,082
+323
| +3% | +$41K | 0.01% | 413 |
|
|
2022
Q2 | $1.55M | Sell |
11,759
-4,479
| -28% | -$588K | 0.01% | 402 |
|
|
2022
Q1 | $2.15M | Sell |
16,238
-199
| -1% | -$23.9K | 0.02% | 376 |
|
|
2021
Q4 | $1.92M | Sell |
16,437
-178
| -1% | -$20.9K | 0.01% | 397 |
|
|
2021
Q3 | $2M | Buy |
16,615
+1,048
| +7% | +$122K | 0.02% | 369 |
|
|
2021
Q2 | $1.86M | Buy |
15,567
+2,989
| +24% | +$328K | 0.02% | 385 |
|
|
2021
Q1 | $1.25M | Buy |
12,578
+2,546
| +25% | +$256K | 0.01% | 437 |
|
|
2020
Q4 | $1M | Sell |
10,032
-1,763
| -15% | -$187K | 0.01% | 454 |
|
|
2020
Q3 | $1.29M | Buy |
11,795
+136
| +1% | +$15.1K | 0.01% | 368 |
|
|
2020
Q2 | $1.23M | Buy |
11,659
+502
| +4% | +$51.8K | 0.01% | 375 |
|
|
2020
Q1 | $997K | Sell |
11,157
-3,892
| -26% | -$366K | 0.01% | 376 |
|
|
2019
Q4 | $1.5M | Buy |
15,049
+459
| +3% | +$43.2K | 0.02% | 350 |
|
|
2019
Q3 | $1.3M | Sell |
14,590
-472
| -3% | -$40.9K | 0.01% | 350 |
|
|
2019
Q2 | $1.24M | Sell |
15,062
-636
| -4% | -$49.9K | 0.01% | 364 |
|
|
2019
Q1 | $1.27M | Buy |
15,698
+1,957
| +14% | +$154K | 0.01% | 365 |
|
|
2018
Q4 | $1.04M | Buy |
13,741
+621
| +5% | +$48.5K | 0.01% | 378 |
|
|
2018
Q3 | $1.04M | Buy |
13,120
+529
| +4% | +$40K | 0.01% | 421 |
|
|
2018
Q2 | $884K | Buy |
12,591
+405
| +3% | +$29.1K | 0.01% | 445 |
|
|
2018
Q1 | $852K | Buy |
12,186
+237
| +2% | +$16.4K | 0.01% | 442 |
|
|
2017
Q4 | $829K | Buy |
11,949
+767
| +7% | +$51.7K | 0.01% | 460 |
|
|
2017
Q3 | $758K | Sell |
11,182
-1,497
| -12% | -$94.6K | 0.01% | 504 |
|
|
2017
Q2 | $864K | Buy |
12,679
+1,450
| +13% | +$94.7K | 0.01% | 472 |
|
|
2017
Q1 | $699K | Buy |
11,229
+3,302
| +42% | +$192K | 0.01% | 583 |
|
|
2016
Q4 | $433K | Buy |
7,927
+1,092
| +16% | +$62K | 0.01% | 690 |
|
|
2016
Q3 | $449K | Buy |
6,835
+1,362
| +25% | +$89K | 0.01% | 678 |
|
|
2016
Q2 | $331K | Sell |
5,473
-407
| -7% | -$23.6K | ﹤0.01% | 720 |
|
|
2016
Q1 | $331K | Buy |
5,880
+197
| +3% | +$11.8K | ﹤0.01% | 723 |
|
|
2015
Q4 | $385K | Buy |
5,683
+101
| +2% | +$6.62K | 0.01% | 678 |
|
|
2015
Q3 | $355K | Sell |
5,582
-123
| -2% | -$8.09K | 0.01% | 708 |
|
|
2015
Q2 | $364K | Sell |
5,705
-241
| -4% | -$16.5K | ﹤0.01% | 720 |
|
|
2015
Q1 | $407K | Buy |
5,946
+719
| +14% | +$50K | 0.01% | 688 |
|
|
2014
Q4 | $368K | Buy |
5,227
+255
| +5% | +$18.3K | ﹤0.01% | 710 |
|
|
2014
Q3 | $355K | Sell |
4,972
-12
| -0.2% | -$878 | ﹤0.01% | 865 |
|
|
2014
Q2 | $370K | Sell |
4,984
-5,383
| -52% | -$389K | ﹤0.01% | 874 |
|
|
2014
Q1 | $673K | Sell |
10,367
-935
| -8% | -$60.4K | 0.01% | 705 |
|
|
2013
Q4 | $671K | Sell |
11,302
-531
| -4% | -$28.8K | 0.01% | 685 |
|
|
2013
Q3 | $615K | Sell |
11,833
-1,280
| -10% | -$64.3K | 0.01% | 684 |
|
|
2013
Q2 | $620K | Buy |
+13,113
| New | +$668K | 0.01% | 654 |
|
Other funds holding AZN
EP
IA
Regions Financial Corp's AZN Position: Q2 2026 in Review
Regions Financial Corp opened a new position in AstraZeneca (AZN) in Q2 2026: 10,014 shares worth $1.9M. The stake represents 0.01% of the portfolio and ranks #382 among its holdings. This is a return to the name: Regions Financial Corp previously reported a position in AZN as recently as Q4 2025.
Regions Financial Corp first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.79M in Q3 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Regions Financial Corp held 10,014 shares of AstraZeneca worth $1.9M as of Q2 2026.
- AstraZeneca was a new Regions Financial Corp position in Q2 2026.
- AstraZeneca made up 0.01% of Regions Financial Corp's portfolio in Q2 2026, its #382 holding.
- Regions Financial Corp first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Regions Financial Corp's AstraZeneca position peaked at $2.79M in Q3 2024.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.